v3.25.3
Share-based Compensation - Schedule of SARs Activity (FY) (Details)
1 Months Ended
Dec. 09, 2024
$ / shares
shares
Dec. 31, 2024
$ / shares
shares
Weighted Average Grant Date Fair Value (per share)    
Outstanding (in usd per share)   $ 6.63
Cash-settled SARs    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Granted (in shares) | shares 30,000  
Vested (in shares) | shares   0
Exercised (in shares) | shares   0
Forfeited (in shares) | shares   0
Non-vested (in shares) | shares   30,000
Exercisable (in shares) | shares   0
Weighted Average Exercise Price    
Granted (in usd per share) $ 12.18  
Vested (in usd per share)   $ 0
Exercised (in usd per share)   0
Forfeited (in usd per share)   0
Outstanding (in usd per share)   12.18
Exercisable (in usd per share)   0
Weighted Average Grant Date Fair Value (per share)    
Granted (in usd per share) $ 38.66  
Vested (in usd per share)   0
Exercised (in usd per share)   0
Forfeited (in usd per share)   0
Outstanding (in usd per share)   38.66
Exercisable (in usd per share)   $ 0
Stock-settled SARs    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Granted (in shares) | shares 320,000  
Vested (in shares) | shares   0
Exercised (in shares) | shares   0
Forfeited (in shares) | shares   0
Non-vested (in shares) | shares   320,000
Exercisable (in shares) | shares   0
Weighted Average Exercise Price    
Granted (in usd per share) $ 12.18  
Vested (in usd per share)   $ 0
Exercised (in usd per share)   0
Forfeited (in usd per share)   0
Outstanding (in usd per share)   12.18
Exercisable (in usd per share)   0
Weighted Average Grant Date Fair Value (per share)    
Granted (in usd per share) $ 38.66  
Vested (in usd per share)   0
Exercised (in usd per share)   0
Forfeited (in usd per share)   0
Outstanding (in usd per share)   38.66
Exercisable (in usd per share)   $ 0